RecruitingPhase 3NCT03949049
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Efficacy of Citicoline as Neuroprotector in Neonates Exposed to Hypoxia: A Randomized Controlled Trial
Sponsor
Sherief Abd-Elsalam
Enrollment
40 participants
Start Date
Feb 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
Eligibility
Max Age: 1 Month
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Citicoline and Placebo for people with neonatal hypoxia. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 1 Month.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGCiticoline
Citacoline as neuroprotector
OTHERPlacebo
placebo group
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03949049